NCT07151690
- Conditions
- Systemic Light Chain Amyloidosis
- Locations
-
- Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China
Clinical trial condition
Systemic Light Chain Amyloidosis
Explore clinical trials studying Systemic Light Chain Amyloidosis. Study availability and eligibility vary by location and protocol.
4 public trials
3 recruiting studies
Systemic Light Chain Amyloidosis trial results
Recruiting
Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis
NCT07626476
- Conditions
- AL Amyloidosis, Amyloidosis, Disease Attributes, +16 more
- Locations
-
- Beijing GoBroad Boren Hospital Beijing, Fengtai District, China
NCT06803082
- Conditions
- Ocular Complications, Systemic Light Chain Amyloidosis
- Locations
-
- Zhongshan Opthalmic Center Guangzhou, Guangdong, China
Completed
A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis
NCT01789242
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +2 more
- Locations
-
- City of Hope Duarte, California, United States
- Stanford Cancer Institute Stanford, California, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Boston University Medical Center Boston, Massachusetts, United States